Tarsons Products Ltd

Tarsons Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tarsons Products Ltd

₹ 219 3.64%
22 May - close price
tarsons.com BSE: 543399 NSE: TARSONS
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)

Website BSE NSE
  • Market Cap ₹ 1,164 Cr.
  • Current Price ₹ 219
  • High / Low ₹ 458 / 164
  • Stock P/E 77.3
  • Book Value ₹ 119
  • Dividend Yield 0.00 %
  • ROCE 4.56 %
  • ROE 2.38 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 4.68% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
76.05 70.66 84.94 61.79 105.72 84.80 99.25 95.68 112.69 91.36 102.33 107.89 120.93
37.58 37.52 40.61 38.91 75.48 66.04 73.94 66.04 75.67 66.66 74.88 76.37 86.66
Operating Profit 38.47 33.14 44.33 22.88 30.24 18.76 25.31 29.64 37.02 24.70 27.45 31.52 34.27
OPM % 50.59% 46.90% 52.19% 37.03% 28.60% 22.12% 25.50% 30.98% 32.85% 27.04% 26.82% 29.21% 28.34%
1.45 2.46 2.58 3.24 3.38 2.91 8.43 0.85 3.78 3.34 5.80 7.07 6.83
Interest 1.56 1.37 0.45 2.51 4.25 4.32 4.84 5.03 5.20 5.07 5.18 6.05 6.25
Depreciation 4.81 5.35 7.24 10.06 12.33 11.03 14.03 17.41 20.03 19.94 22.48 25.04 29.08
Profit before tax 33.55 28.88 39.22 13.55 17.04 6.32 14.87 8.05 15.57 3.03 5.59 7.50 5.77
Tax % 25.78% 25.66% 24.89% 26.72% 39.50% 36.39% 30.80% 34.66% 34.49% 41.25% 40.61% 32.93% 27.56%
24.90 21.47 29.46 9.93 10.32 4.02 10.29 5.26 10.20 1.78 3.32 5.04 4.18
EPS in Rs 4.89 4.04 5.54 1.87 1.94 0.76 1.93 0.99 1.92 0.33 0.62 0.95 0.79
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
229 301 296 392 423
125 148 196 282 305
Operating Profit 103 153 100 111 118
OPM % 45% 51% 34% 28% 28%
5 8 11 16 23
Interest 3 4 10 20 23
Depreciation 14 22 40 62 97
Profit before tax 92 135 61 45 22
Tax % 25% 25% 30% 34% 35%
69 101 43 30 14
EPS in Rs 3,583.25 18.92 8.01 5.60 2.69
Dividend Payout % 0% 0% 25% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: %
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: -26%
3 Years: %
TTM: -49%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -26%
1 Year: -46%
Return on Equity
10 Years: %
5 Years: %
3 Years: 5%
Last Year: 2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.19 11 11 11 11
Reserves 244 479 602 620 624
34 22 269 339 393
18 33 90 111 158
Total Liabilities 296 544 972 1,080 1,186
120 189 336 536 733
CWIP 22 32 267 233 159
Investments 0 0 0 0 0
153 323 369 311 295
Total Assets 296 544 972 1,080 1,186

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
68 83 103 114 118
-64 -138 -285 -145 -130
-27 130 136 39 9
Net Cash Flow -23 75 -47 8 -3
Free Cash Flow 6 -48 -81 -37 -7
CFO/OP 89% 77% 121% 117% 107%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
Debtor Days 75 79 96 74 74
Inventory Days 277 478 572 355 341
Days Payable 35 75 65 44 53
Cash Conversion Cycle 317 482 602 385 361
Working Capital Days 108 150 -1 38 -20
ROCE % 35% 7% 5%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2025
Days Inventory Outstanding
Days

Log in to view insights

Please log in to see hidden values.

Login
Average Collection Period
Days
Number of Domestic Distributors
Count ・Standalone data
Number of International Distributors
Count ・Standalone data
Number of Manufacturing Machines
Count ・Standalone data
Number of Manufacturing Moulds
Count ・Standalone data
Number of SKUs
Count ・Standalone data
Domestic Labware Market Share
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.30% 47.30%
8.64% 7.85% 6.83% 8.16% 7.95% 8.04% 7.51% 9.53% 9.14% 5.82% 2.46% 0.87%
7.38% 3.15% 2.60% 0.17% 0.11% 0.21% 0.51% 0.30% 0.04% 0.08% 0.00% 0.19%
36.67% 41.68% 43.27% 44.36% 44.63% 44.45% 44.69% 42.89% 43.50% 46.79% 50.23% 51.65%
No. of Shareholders 1,07,4401,08,2361,07,5641,02,8661,05,33099,58696,92793,41790,89188,96687,33684,093

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls